From The Stage

Investing in Emerging Bioanalytical Technologies: A Balancing Act

Posted by / / BioAgilytix Insight, Bioanalytical Platforms

Technology plays a critical part in everything we do as a bioanalytical laboratory. Ensuring that we have leading-edge platforms and instrumentation, as well as subject matter experts who can effectively operate them, are paramount concerns for our operation, so that we can capture and deliver robust, accurate scientific data in an efficient manner. When making technology purchasing decisions, there are a number of factors to consider – from cost to market needs to available talent. Each must be carefully weighed in order to maximize the ROI of any technology investments…

Novel Circulating Biomarkers and Pathways May Help Predict Type 2 Diabetes More Efficiently

Posted by / / BioAgilytix Insight, Biomarkers

In 2015, 29 million people in the United States had type 2 diabetes, according to the American Diabetes Association. Type 2 diabetes is generally a result of a decline in beta cell function, however this indicator is rarely measured because of flaws in the current method of assessment that can lead to inaccurate results. As such, definitively diagnosing this disease is difficult. Early intervention in those at risk for type 2 diabetes is crucial to the patient’s overall outlook for recovery or for successful disease management. Diagnosis of this disease…